Zai Labs Stock: Biopharma's Alibaba, But Better (NASDAQ:ZLAB)
Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.
Source: seekingalpha.com
📰 While Zai Lab News
While Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from While Zai Lab. Real-time updates on events, politics, business and more.